E-mail lunthesis@163.com Phone 0551-65179860-203

China greenlights new COVID-19 vaccine candidate for human trials

Pub Date:2020-06-28 09:08 Source:Xinhua

Chinese authorities have approved a new COVID-19 vaccine candidate for human trials, the Institute of Microbiology under the Chinese Academy of Sciences, said in a statement.

The recombinant protein vaccine was issued with a clinical research permit from the National Medical Products Administration on June 19, according to the institute, which is the vaccine's main developer.

Researchers will start phase-1 clinical trials in hospitals in Chongqing and Beijing, to determine whether the vaccine is safe for use on humans, its co-developer Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. confirmed.

It represents the third type of COVID-19 vaccine developed by Chinese researchers to enter clinical trials. One adenovirus vaccine and four inactivated vaccines have previously been approved for human tests in China, with some having just cleared phase-2 trials. 


Editor:Rita

Related News
- China adds 119 drugs to medicare reimbursement list    2020-12-29 08:37
- Anhui starts its emergency vaccination project amid spora...    2020-12-28 08:53
- COVID-19 virus reported for first time on locally-produce...    2020-12-18 09:11
- Authorities investigate fake hospital insurance claims    2020-12-17 10:42
 
photo  >>
Wuhu, Anhui: 100,000 mu of canola flowers blossoming
Guest countries of honor attract visitors at 6th CIIE
Video  >>
【网络中国节·元宵】 Happy Lantern Festival! Intangible cultural heritage in Anhui—— Fish Lantern 一夜“鱼”龙舞
2024 Chinese New Year: OMG! The God of Wealth is at your door!
People  >>
Hebei rolls out red carpet for talent
Transnational couple revives ancient dwelling in east China
Travel  >>
Huangshan listed among China's Top 10 scenic cities
China expects travel spree during May Day holiday
Contact Us
Copyright ©2000-2021 anhuinews.com All rights reserved. Reproduction in whole or in part without permission is prohibited. 皖B2-20080023-7